I found the complete article referenced in the Anderson and Valdez galactagogue study review.  This is the study that found a 3.8 fold greater risk of sudden cardiac death in those taking domperidone as opposed to matched controls.  As far as I could tell, this was not a study of ill patients who were on IV domperidone as mentioned by those who discount the cardiac concern as it applies to healthy people.

http://eurheartj.oxfordjournals.org/content/26/19/2007.full

I would be interested in others opinion of this study and the implications for recommending domperidone as a galactagogue.  I hope this all is answered when this drug is more thoroughly studied due to its orphan drug status.  In the mean time, I still feed uncomfortable with recommending it as a "safe" galactagogue.

Laura Spitzfaden, LLLL, IBCLC

             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome